Table 1 Demographic and baseline clinical characteristics of 200 persons living with HIV (PLWH) and controls in baseline mUTIMA study cohort. Percentages/proportions are represented in parentheses. P-values are calculated using t-tests, chi-squared tests, and two-proportion z-test for continuous, categorical, and binary variables, respectively
PLWH (n = 100) | Control (n = 100) | P (PLWH vs. Control) | |
|---|---|---|---|
Age, years (mean ± SD) | 55.3 ± 6.3 | 56 ± 6.7 | 0.47 |
Age group categories (n) | 0.68 | ||
45–54 | 50 (50) | 44 (44) | |
55–64 | 41 (41) | 45 (45) | |
65 + | 9 (9) | 11 (11) | |
ASCVD risk group (n) | 0.25 | ||
Low (< 5%) | 37 (37) | 25 (25) | |
Borderline (5–7.5%) | 20 (20) | 19 (19) | |
Intermediate (7.5–10%) | 14 (14) | 19 (19) | |
High (> 10%) | 29 (29) | 37 (37) | |
Past Medical History (n) | |||
Diabetes | 26 (26) | 45 (45) | 0.008* |
Hypertension | 89 (89) | 81 (81) | 0.17 |
Current smoker | 4 (4) | 4 (4) | 0.99 |
BMI | 0.14 | ||
Normal | 28 (28) | 17 (17) | |
Overweight | 34 (34) | 32 (32) | |
Obese | 36 (36) | 50 (50) | |
Underweight | 2 (2) | 1 (1) | |
Waist-to-hip ratio (mean ± SD) | 0.94 ± 0.12 | 0.89 ± 0.08 | 0.001* |
Abdominal obesity (high WHR†) | 76 (76) | 63 (63) | 0.07 |
Chronic kidney disease | 15 (15) | 10 (10) | 0.39 |
GFR (mean ± SD) | 98 ± 22.6 | 103 ± 23.6 | 0.14 |
Abnormal urine ACR ‡ | 30 (30) | 21 (21) | 0.19 |
High total cholesterol | 58 (58) | 56 (56) | 0.89 |
High low-density lipoprotein cholesterol | 51 (51) | 60 (60) | 0.26 |
Low high-density lipoprotein cholesterol | 54 (54) | 72 (72) | 0.01* |